YVER ANTOINE 4
4 · Centessa Pharmaceuticals plc · Filed Jan 13, 2023
Insider Transaction Report
Form 4
YVER ANTOINE
EVP & Chairman of Development
Transactions
- Tax Payment
Ordinary Shares
[F1][F2][F3][F4]2022-09-30$4.25/sh−7,732$32,861→ 782,019 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
- [F3]Shares held by the Reporting Person after the reported transaction herein and does not include shares acquired or disposed of in subsequent reported transactions after September 30, 2022.
- [F4]As of year end December 31, 2022, the Reporting Person held 751,151 shares directly.
Signature
/s/ Gregory Weinhoff, attorney-in-fact|2023-01-13